Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04938960 · ClinicalTrials.gov registry record
Identification of Non-gal, Non-HLA Antigens in Patients Implanted With Xenogenic Material
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 197
- Enrollment target
NCT04938960: Completed study, sponsored by Mayo Clinic.
NCT04938960 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 197 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04938960 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 197 participants
- Enrollment target
Study Summary
This study involves collecting serum samples from patients presenting for aortic valve replacement at Mayo Clinic, Rochester, MN. Serum samples will be collected pre-op, between 2 weeks and 3 months, between 3-11 months (optional), and between 12-18 months post-operatively. The patients antibodies in these serum samples will be used to capture proteins from the same type of tissue their replacement heart valves are made from (i.e., bovine/porcine pericardium - a non-human tissue which is currently used to make glutaraldehyde-fixed heart valves). The captured proteins will be identified, and compared over time (i.e., 0, 1, 3 and 12 months) to determine which proteins (i.e., antigens) in bovine/porcine pericardium that the patient is mounting an immune response towards.
Interventions
- DIAGNOSTIC_TEST blood draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 197 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2024-09-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04938960
The ClinicalTrials.gov registry entry for NCT04938960 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 197 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which blood draw is the first listed.
NCT04938960 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04938960 about?
NCT04938960 is a clinical study titled "Identification of Non-gal, Non-HLA Antigens in Patients Implanted With Xenogenic Material". This study involves collecting serum samples from patients presenting for aortic valve replacement at Mayo Clinic, Rochester, MN. Serum samples will be collected pre-op, between 2 weeks and 3 months, between 3-11 months (optional), and between 12-18 months post-operatively. The patients antibodies i...
What is the current status of trial NCT04938960?
This trial is currently completed. The enrollment target is 197 participants. The study started on 2021-07-01. Estimated completion is 2024-09-05.
What interventions are being tested in trial NCT04938960?
The interventions under investigation include: blood draw (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04938960?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.